Manulife (Manufacturers Life Insurance)
GTBP icon

Manulife (Manufacturers Life Insurance)’s GT Biopharma GTBP Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-459
Closed -$213K – 3174
2021
Q2 		$213K Buy
+459
New +$191K ﹤0.01% 3062

Other funds holding GTBP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCP
Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GTBP Position: Q3 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of GT Biopharma (GTBP) in Q3 2021, closing a stake of 459 shares — an estimated $213K sold.

Manulife (Manufacturers Life Insurance) first reported a position in GTBP in Q2 2021 and held it in 1 quarter. The position peaked at $213K in Q2 2021. 53 funds tracked by Wall St. Rank hold GTBP as of Q3 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining GT Biopharma position as of Q3 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 459 GT Biopharma shares in Q3 2021, an estimated $213K.
  • Manulife (Manufacturers Life Insurance) first reported a position in GT Biopharma in Q2 2021 and held it in 1 quarter.
  • Manulife (Manufacturers Life Insurance)'s GT Biopharma position peaked at $213K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held GT Biopharma as of Q3 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2021, filed 12 Nov 2021.